MENU
+Compare
HIMS
Stock ticker: NYSE
AS OF
Dec 3 closing price
Price
$37.07
Change
+$0.76 (+2.09%)
Capitalization
8.44B

HIMS Hims & Hers Health Forecast, Technical & Fundamental Analysis

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss... Show more

HIMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HIMS with price predictions
Nov 28, 2025

HIMS in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 13, 2025

HIMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 41 cases where HIMS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HIMS's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on HIMS as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HIMS just turned positive on November 25, 2025. Looking at past instances where HIMS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HIMS advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for HIMS crossed bearishly below the 50-day moving average on October 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HIMS entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HIMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.535) is normal, around the industry mean (17.312). P/E Ratio (69.943) is within average values for comparable stocks, (72.847). Projected Growth (PEG Ratio) (2.035) is also within normal values, averaging (1.956). HIMS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (4.252) is also within normal values, averaging (55.504).

View a ticker or compare two or three
HIMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HIMS is expected to report earnings to fall 13.83% to 5 cents per share on March 02

Hims & Hers Health HIMS Stock Earnings Reports
Q4'25
Est.
$0.05
Q3'25
Missed
by $0.04
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.06
The last earnings report on November 03 showed earnings per share of 5 cents, missing the estimate of 10 cents. With 10.88M shares outstanding, the current market capitalization sits at 8.44B.
A.I. Advisor
published General Information

General Information

a company, which is involved in real estate investment trusts

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
2269 Chestnut Street
Phone
+1 415 851-0195
Employees
658
Web
https://www.forhims.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
RUBCHF0.010.00
+0.13%
Russia Ruble - Switzerland Franc
GMXRX16.28N/A
N/A
Nationwide Mid Cap Market Idx R
ABAEX10.15N/A
N/A
AB Emerging Markets Multi-Asset A
MSCMX17.02N/A
N/A
Morgan Stanley Insight C
ANOYX25.19N/A
N/A
American Century Small Cap Growth Y

HIMS and Stocks

Correlation & Price change

A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-3.23%
COTY - HIMS
31%
Poorly correlated
+0.75%
TKNO - HIMS
30%
Poorly correlated
-5.36%
EWCZ - HIMS
30%
Poorly correlated
+0.89%
ALKS - HIMS
26%
Poorly correlated
+0.24%
EOLS - HIMS
24%
Poorly correlated
-4.40%
More

Groups containing HIMS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-3.23%
Pharmaceuticals: Generic
industry (213 stocks)
38%
Loosely correlated
+0.76%
Pharmaceuticals
industry (377 stocks)
23%
Poorly correlated
+0.67%